• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.00% Nasdaq Up 1.66%

    Intercept Pharmaceuticals, Inc. (ICPT)

    -NasdaqGS
    120.22 Up 25.93(27.50%) Feb 12, 4:00PM EST
    |After Hours : 119.90 Down 0.32 (0.27%) Feb 12, 7:59PM EST
    Prev Close:94.29
    Open:95.36
    Bid:119.75 x 600
    Ask:122.00 x 200
    1y Target Est:320.50
    Beta:-2.9199
    Earnings Date:Feb 29 - Mar 4 (Est.)
    Day's Range:91.50 - 128.75
    52wk Range:89.76 - 314.88
    Volume:4,069,691
    Avg Vol (3m):639,597
    Market Cap:2.93B
    P/E (ttm):N/A
    EPS (ttm):-7.54
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ICPTUp 27.50%2.93B
    SLXP 0.00%10.88B
    AZNUp 1.75%74.98B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):824.76
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-9.15
    Quarterly EPS Est (Dec-15) :-3.15
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):-1.88

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Intercept Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics to treat chronic liver and intestinal diseases utilizing its proprietary bile acid c... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback